SEC Form 4 · accession 0001140361-15-019019
REPLIGEN CORP · RGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Walter C Herlihy
Officer — PRESIDENT, CEO · Director
Period of report
May 8, 2015
Accepted (ET)
May 12, 2015 · 1:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000730272
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 8, 2015 | S | 68,854 | $37.55 | D | 353,576 | D | |
| Common StockF2 | May 11, 2015 | S | 35,715 | $38.6843 | D | 317,861 | D | |
| Common Stock | May 11, 2015 | G | 10,000 | $0.00 | D | 307,861 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1$37.55 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.90 to $38.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2$38.6843 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.22 to $39.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.